Medication info
Lansira Capsule 30 mg (Lansoprazole Granules)

Lansira Capsule 30 mg (Lansoprazole Granules)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole Granules›353mg / 1 capsule
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
A hard capsule in white to pale brown containing granules.
Packaging
28 capsules/bottle
Approval status
Active

MFDS item code 202001896 · Approved 2020.03.18 · Insurance code 698004220

Summary

Main use
Treatment and prevention of ulcers and eradication of Helicobacter pylori, treatment of reflux disease, suppression of excessive gastric acid secretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice or more the amount of juice and drink immediately to ensure the entire dose is taken. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer 15 mg of lansoprazole orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer 30 mg of lansoprazole orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer Administer 30 mg of lansoprazole with 250 ∼ 500 mg of clarithromycin and 1,000 mg of amoxicillin twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Administer 30 mg of lansoprazole with 1,000 mg of amoxicillin three times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer 15 mg of lansoprazole orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer 30 mg of lansoprazole orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer 15 mg of lansoprazole orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer 15 mg of lansoprazole orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer 30 mg of lansoprazole orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer 15 mg of lansoprazole orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. Treatment in adults is generally initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and treatment may be continued for as long as it is clinically effective. Doses of 90 mg per administration have been given up to twice daily. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in older adults, dosage adjustment is required. Do not exceed a daily dose of 30 mg. Use with caution, including dosage adjustment, in patients with hepatic impairment, as metabolism and excretion of this medicine may be delayed.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Treatment and prevention of ulcers and eradication of Helicobacter pylori, treatment of reflux disease, suppression of excessive gastric acid secretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer
  • NSAID-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive esophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion.
View approved original text

This medication is used for the short-term treatment of active duodenal ulcers and active benign gastric ulcers. It also eradicates Helicobacter pylori to prevent the recurrence of duodenal ulcers and aids in maintenance therapy after treatment. It is effective for treating gastric ulcers induced by non-steroidal anti-inflammatory drugs and reducing the risk of gastric ulcer occurrence. Additionally, it is used for the short-term treatment of gastroesophageal reflux disease and erosive esophagitis, as well as maintenance therapy. Finally, it improves pathological hypersecretion conditions such as Zollinger-Ellison syndrome.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice or more the amount of juice and drink immediately to ensure the entire dose is taken. After opening the capsule, do not chew or crush the contents before taking them. Short-term treatment of active duodenal ulcer: Administer 15 mg of lansoprazole orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcer: Administer 30 mg of lansoprazole orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcer Administer 30 mg of lansoprazole with 250 ∼ 500 mg of clarithromycin and 1,000 mg of amoxicillin twice daily (every 12 hours) for 7 days. Treatment may be continued for up to 14 days if needed. Administer 30 mg of lansoprazole with 1,000 mg of amoxicillin three times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcer: Administer 15 mg of lansoprazole orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcer: Administer 30 mg of lansoprazole orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcer: Administer 15 mg of lansoprazole orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer 15 mg of lansoprazole orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer 30 mg of lansoprazole orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer 15 mg of lansoprazole orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. Treatment in adults is generally initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and treatment may be continued for as long as it is clinically effective. Doses of 90 mg per administration have been given up to twice daily. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in older adults, dosage adjustment is required. Do not exceed a daily dose of 30 mg. Use with caution, including dosage adjustment, in patients with hepatic impairment, as metabolism and excretion of this medicine may be delayed.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in certain patients. Patients with allergies or a history of hypersensitivity to this drug or its components, or to benzimidazole derivatives, may experience severe allergic reactions and should avoid this medication. Caution is also needed for patients allergic to penicillin or macrolide antibiotics when used in combination. Pregnant or breastfeeding women should refrain from using this drug, and caution is advised when used in combination with certain antiviral drugs. This drug should be used cautiously in patients with impaired liver function, elderly patients, nursing mothers, and children. Serious allergic reactions, blood abnormalities, liver dysfunction, and severe skin reactions may rarely occur during treatment. If such symptoms appear, consult a doctor immediately. Long-term use may lead to vitamin B12 deficiency, necessitating regular check-ups. There may be a slight increase in the risk of gastrointestinal infections. Moreover, this medication can interact with other drugs, so inform healthcare providers if you are taking other medications. Dizziness or drowsiness may occur during use, so caution is required when driving or operating machinery. There is no specific antidote for overdose; however, gastric lavage or symptomatic treatment may be necessary depending on symptoms. This medication should be kept out of reach of children, and it is safer not to transfer it to other containers. Lastly, it is important to adhere to the recommended dosage and duration, while administering the minimum effective dose as monitoring clinical progress.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute kidney failure, membranous colitis, hematochezia, abdominal pain, diarrhea, headache, abdominal distension, allergic reaction, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, malaise, nuchal rigidity, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stool, gastroenteritis, gastritis, gastric disorders, gastric diseases, gastrointestinal bleeding, loss of appetite, bezoar, pyloric spasm, cholelithiasis, constipation, polydipsia, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, fecal discoloration, distension, gastric nodules, gastric fundic gland polyp, gastroenteritis, peptic ulcer bleeding, hematemesis, increased appetite, hypersalivation, anal bleeding, stomatitis, tongue disorders, glossitis, gingival bleeding, rectal urgency, colitis, vomiting, nausea, diarrhea, gastric candidiasis, rectal disorders, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone diseases, joint diseases, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, anxiety, amnesia, restlessness, confusion, depression, dizziness, syncope, hallucination, unilateral paralysis, exacerbation of hostility, decreased libido, increased libido, neurosis, sensory abnormalities, abnormal thought, seizures, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory loss syndrome, insomnia, sleep disorder, somnolence, tremors, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataracts, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, taste distortion, tinnitus, visual field constriction, urinary dysfunction, nephralgia, penile disorders, testicular disorders, urethral pain, polyuria, urinary frequency, urinary retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, renal stones, hepatotoxicity, pancreatitis, taste disorders, aplastic anemia, leukopenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fracture, myositis, erythema multiforme, acute generalized exanthematous pustulosis, speech disorders, urinary hesitancy, elevated ALP, elevated LDH, elevated γ-GTP, fatigue, hyponatremia, elevated total cholesterol, decreased total cholesterol, tongue paralysis, lip paralysis, quadriplegia, abdominal pain, urination, abdominal bloating, heartburn, gastroesophageal reflux, neutropenia, leukocytosis, thrombocytopenia, rash, pruritus, drowsiness, insomnia, paralysis, depressive state, elevated triglycerides, elevated uric acid, positive urinary protein, positive urinary glucose, malaise, increased AST, increased ALT, increased creatinine, increased globulin, abnormal WBC, abnormal AG ratio, abnormal RBC, hyperbilirubinemia, abnormal serum potassium, abnormal urinary potassium, crystalluria, decreased hemoglobin, hyperlipidemia, electrolyte abnormalities, cholesterol abnormalities, increased glucocorticoids, abnormal platelets, increased gastrin concentration, positive occult blood in stool, albuminuria, hematuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

A hard capsule in white to pale brown containing granules.

Package unit

28 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.